MANERIX
BAUSCH HEALTH, CANADA INC.
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is MANERIX discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that MANERIX 300MG has been permanently discontinued (last updated January 8, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is MANERIX not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
RATIO-MOCLOBEMIDE - TAB 300MG
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
TEVA-MOCLOBEMIDE
TEVA CANADA LIMITED
RIVA-MOCLOBEMIDE 300MG TABLETS
LABORATOIRE RIVA INC.
DOM-MOCLOBEMIDE TABLETS 300MG
DOMINION PHARMACAL
Other Products
MANERIX TAB 100MG
HOFFMANN-LA ROCHE LIMITED
RATIO-MOCLOBEMIDE - TAB 150MG
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02166747
Strength
300MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
MOCLOBEMIDE
Tier
Unrated
Last Updated
2025-01-08
Reason for Shortage
Business reasons
Other Products from BAUSCH HEALTH, CANADA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.